News Banner

OUR EXECUTIVE LEADERSHIP TEAM

Syed E Abidi

Syed E. Abidi, Ph.D.

Executive Chairman

John Fowler_Pres_CEO

John Fowler

President and CEO

John Guthrie

John Guthrie

Chief Financial Officer

Thomas G. Pamukcoglu

Tom Pamukcoglu

Vice President of Quality

Christian Ahlmark

Christian Ahlmark

Vice President of Business Development

Syed E Abidi

Syed E. Abidi, Ph.D.
Executive Chairman

Syed E. Abidi, Ph.D. has over 30 years of experience in pharmaceutical formulation development and is an original founding member of Pii. Dr. Abidi has extensive experience in dosage form development, including capsules, tablets, modified-release tablets, suspensions, solutions, small volume parenterals, suppositories, creams, ointments, gels, inhalation aerosols and transdermals. He also has experience with pre-approval inspection preparation and with the scale-up and launch of major pharmaceutical products (both prescription and OTC).

Prior to joining Pii, Dr. Abidi served as the Vice President of American Drug Development, Inc. from 1994 to 1995, where he was responsible for research and development activities. He also worked as the Director of Pharmaceutics at Hercon Laboratories, as a Principal Scientist for Applied Analytical, Inc., and as a Senior Scientist for Schering-Plough Pharmaceuticals.

Dr. Abidi earned his B.S. in Pharmacy from Karachi University in Pakistan in 1975, and his M.S. and Ph.D. in Pharmaceutics from the University of Mississippi in 1977.

John Fowler_Pres_CEO

John Fowler
President and CEO

Mr. John Fowler brings more than 30 years of pharmaceutical and chemical industry experience to Pii. He most recently served as President and Chief Operating Officer of Piramal Pharma Solutions, a CDMO serving generic companies worldwide. Prior to joining Piramal, he was the Divisional CEO of the Global Fine Chemical business at Johnson Matthey. Mr. Fowler also held senior leadership roles in several business verticals at JM, including Pharmaceutical Materials and Services, Environmental Catalysts, and Technologies, among others. He has a Chemical Engineering degree from Bucknell University and an MBA from St. Joseph University.

John Guthrie

John Guthrie
Chief Financial Officer

John Guthrie joined Pii in June 2018 as Chief Financial Officer.

Prior to Pii, John was Managing Director and Chief Operating Officer of Motir DuSable Power Investments, a renewable energy company focused on Sub-Saharan Africa. In earlier years he served in CFO roles in the technology, printing and plastics industries and began his career at Deloitte.

He is a CPA and has an M.B.A. and B.A. from Loyola University (Baltimore).

Thomas G. Pamukcoglu

Tom Pamukcoglu
Vice President of Quality

Tom Pamukcoglu has an extensive history overseeing the manufacture of sterile drugs, biologics, and vaccines in both Quality and Manufacturing roles. He brings a wealth of knowledge in aseptic processing, quality system design and implementation, and process validation to Pii. Tom previously served as Head of Quality – Sterile Solutions at ICU Medical. Prior to ICU, he held Quality leadership roles at Cognate, Lonza, AstraZeneca, Medimmune, SAFC Biosciences, and Abbott/Hospira. Tom is trained in Six Sigma, CAPA, TQM, and Lean Manufacturing, and he holds a certificate from the University of Tennessee Parenteral Drug Manufacturing program. He has a Master of Business Administration, Management from Canisius College and a Bachelor of Science in Biology/Chemistry from State University of New York at Albany.

Christian Ahlmark

Christian Ahlmark
Vice President of Business Development

With more than 30 years of experience in pharma contract service operations, Mr. Christian Ahlmark joins Pii as Vice President of Sales and Business Development. A respected sales leader and account executive, his knowledge of injectable and solid drug product and API development and manufacture ranges from clinic to commercial, domestic to international. Mr. Ahlmark most recently serviced as Vice President Business Development, North America, for IDT Biologika. He also held lead sales and business positions at Corden Pharma International, Kemwell Biopharma, CoreRx Inc., Lancaster Labs, Inc., and Applied Analytical Inc. (now Alcami). Mr. Ahlmark was also a co-founder of Magellan Laboratories Inc. (now Catalent Pharma Services).